Company News

Neutrogena Debuts New Clinical Range

Anti-aging formulations with bioelectric technology.

Author Image

By: TOM BRANNA

Editor

After years of research and ten new technology patents, Neutrogena introduces Neutrogena Clinical, featuring a breakthrough new anti-aging technology known as Ion2Complex to revitalize the look of collagen-depleted skin.

To develop the range, scientists at Neutrogena looked to the power of bioelectricity, the body’s innate electrical signaling system. Bioelectricity directs physiological activities at the cellular level, meaning it allows cells to “talk” with one another and execute marching orders, according to the company.

After studying the field of bioelectricity for over two years Neutrogena scientists discovered a way to create tiny essential ion-mineral conductors within a topical formulation. Once activated they work like “miniaturized batteries” to simulate bioelectricity and increase positive ion flow, to help minimize visible signs of collagen loss by increasing resilience of the skin for noticeably improved facial definition, and a reduction in the appearance of wrinkles and sagging skin.

Neutrogena Clinical arrives in stores the first week of March and is currently available at www.neutrogenaclinical.com. Read more about the line in the May 2010 edition of Happi.

Keep Up With Our Content. Subscribe To Happi Newsletters